Press releasePRNewswire
SOPHiA GENETICS SA
SOPH · NASDAQ
$6.93+$0.44 (+6.78%)TodayMarket closed ·
Prev close $6.49
Latest news
- Press releasePRNewswire
SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology
- Press releasePRNewswire
SOPHiA GENETICS Reports Second Quarter 2026 Results
- Press releasePRNewswire
SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies
- Press releasePRNewswire
SOPHiA GENETICS to Announce Financial Results for Second Quarter 2026 on August 4, 2026
- Press releasePRNewswire
SOPHiA GENETICS Publishes Results of the 2026 Annual General Meeting
- Press releasePRNewswire
SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares
- NewsRishabh Mishra
Stock Market Today: Dow Futures Tumble, S&P 500, Nasdaq Gains As Investors Await FOMC Decision— Amkor, La-Z-Boy In Focus (UPDATED)
- NewsAvi Kapoor
CarMax, Jabil And 3 Stocks To Watch Heading Into Wednesday
- Press releasePRNewswire
SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares
- Press releasePRNewswire
SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares
- Press releasePRNewswire
SOPHiA GENETICS Confirms Leadership Transition Ahead of 2026 Annual General Meeting
- Press releasePRNewswire
SOPHiA GENETICS Signs Strategic Collaboration MOU with Leading Global Cancer Center
- Press releasePRNewswire
Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K.
- News
Earnings Scheduled For May 5, 2026
- Press releasePRNewswire
SOPHiA GENETICS Reports First Quarter 2026 Results
- Press releasePRNewswire
SOPHiA GENETICS to Announce Financial Results for First Quarter 2026 on May 5, 2026
- Press releasePRNewswire
Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026
- News
Sophia Genetics Q4 Earnings Summary & Key Takeaways
- Press releasePRNewswire
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results
- News
Earnings Scheduled For March 3, 2026
- News
A Look at Sophia Genetics's Upcoming Earnings Report
- Press releasePRNewswire
SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference
- Press releasePRNewswire
SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026
- Press releasePRNewswire
SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems
- Press releasePRNewswire
SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan
- Press releasePRNewswire
SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology
- Press releasePRNewswire
AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave
- Press releasePRNewswire
Complete Genomics and SOPHiA GENETICS Announce Integration of MSK-IMPACT® and MSK-ACCESS® Assays on DNBSEQ-T1+ Platform at AMP 2025
- Press releasePRNewswire
SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision Medicine
- Press releasePRNewswire
SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine
- Press releasePRNewswire
SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance
- News
Earnings Scheduled For August 5, 2025
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- News
Exploring Sophia Genetics's Earnings Expectations
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.